Should Hexo (TSX:HEXO) Investors Be Alarmed After the CFO’s Sudden Departure Just Weeks Before Earnings?

Hexo Corp (TSX:HEXO)(NYSE:HEXO) was down on Monday, as investors reacted to a surprise announcement that took place late last week.

| More on:
Businessmen teamwork brainstorming meeting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Last week, we learned that Hexo’s (TSX:HEXO)(NYSE:HEXO) recently hired CFO Michael Monahan was resigning, just months after taking the job back in May. What’s surprising is that he cited location — Hexo is based the Gatineau-Ottawa area — as one of the key reasons as to why he would be resigning from the position. While the reasons could very well be legitimate, any time there’s a high-ranking official leaving a company, especially one in the cannabis industry, it’s going to raise some eyebrows and have some people second-guessing the reasons.

Why the departure of a CFO can be concerning to investors

One of the reasons investors can get spooked about a CFO leaving the company is that it’s such a critical position in the company. Whether it’s drawing up forecasts or ensuring that financial figures are accounted for properly, it’s a role that has a lot of responsibility and one that investors pay close attention to. And indeed, on Monday, the first day investors had a chance to react to the news, the stock fell by 6.6%. It’s a considerable drop for a stock that had been making some decent gains in the days prior to the decline. Whether it’s a coincidence or not is hard to gauge; after all, cannabis stocks have been very volatile this year.

But with Hexo coming under fire because it could be in trouble with regulators, investors may be on a bit of high alert given the problems we’ve seen with CannTrust and other companies this year. Another reason investors may have bolted is that the company has also made some pretty lofty goals for 2020, projecting sales to reach $400 million during the fiscal year. That would have to be some explosive growth for the company given that over the past three quarters, sales have totalled just over $32 million.

And to add more conspiracy into the mix, Hexo is also expected to release its quarterly results later this month. There are no shortage of reasons as to why Hexo investors may be more than a little alarmed by the news and suspicious of the reasons behind it. But even if it turns out to simply be coincidental, turnover at that position is still not what investors like to see, as it’s a role that’s very important and that companies typically spend a lot of time recruiting for to ensure that they fill it with the right candidate.

Takeaway for investors

Hexo’s share price has fallen more than 40% in just the past six months. With cannabis companies underperforming this year, a CFO leaving his post just weeks before earnings is something I wouldn’t completely ignore, especially given how short the tenure has been. With everything taking into consideration, I’d be surprised if Hexo impresses investors this month with its earnings results, as the writing could very well be on the wall.

Overall, there’s simply too much volatility in the industry right now, and this move isn’t going to instill any additional confidence in the company heading into earnings. Investors may want to exercise some caution on Hexo in light of these developments and hold off on buying the stock for now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »